financing

News

Electra banks $183m for sHLH drug, and other biofinancings

Our round-up of recent biotech financings includes a big round for Electra, with Hemab, Zag Bio, Elevara, Expedition, and Curve also adding new funds.

News

Lila Sciences' swollen first round, and other biofinancings

AI-powered autonomous lab firm Lila Sciences upsizes its Series A to $350m, heading a bumper week for new biotech financings.

News

Dr Dominik Schumacher, Tubulis' co-founder and chief executive

Germany's Tubulis raises €308m for ADC pipeline

Ahead of a data reveal at ESMO, Tubulis has raised €308m to help fund clinical trials of its antibody-drug conjugate for ovarian cancer.

News

Ron Renaud, president and chief executive of Kailera

$600m round will help Kailera push obesity drug into phase 3

Kailera Therapeutics has raised an eye-watering $600 million in Series B financing to take its lead drug for weight loss into pivotal trials.

News

Close up in sepia on Benjamin Franklin face on cash note

Soufflé's tasty $200m raise, and other biofinancings

New biotech financings include nine-figure rounds for Soufflé, Expedition, Arthrosi, and Nilo Therapeutics, with NanoPhoria and TORL not far behind.

News

Dr Ken Macnamara, Trogenix's chief executive

UK's Trogenix raises £70m for cancer immunotherapy platform

Edinburgh-based Trogenix has raised £70m to fund clinical trials of its triple-acting immunotherapies for brain and colorectal cancers.

Electra banks $183m for sHLH drug, and other biofinancings

Lila Sciences' swollen first round, and other biofinancings

Germany's Tubulis raises €308m for ADC pipeline

$600m round will help Kailera push obesity drug into phase 3

Soufflé's tasty $200m raise, and other biofinancings

UK's Trogenix raises £70m for cancer immunotherapy platform

Remepy's hybrid Parkinson's therapy poised for phase 3

Discover a new era of healthcare panel engagement: Grounded ...

financing

Editor's Picks